UK markets close in 2 hours 7 minutes

FibroGen, Inc. (0IL8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.1504+0.0608 (+5.58%)
As of 06:56PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-90.06%
S&P500 52-week change 323.06%
52-week high 320.7950
52-week low 30.0000
50-day moving average 31.5820
200-day moving average 32.7905

Share statistics

Avg vol (3-month) 328.08k
Avg vol (10-day) 327k
Shares outstanding 584.98M
Implied shares outstanding 6N/A
Float 882.99M
% held by insiders 16.37%
% held by institutions 171.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -192.37%
Operating margin (ttm)-381.26%

Management effectiveness

Return on assets (ttm)-35.54%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)147.75M
Revenue per share (ttm)1.52
Quarterly revenue growth (yoy)-21.00%
Gross profit (ttm)N/A
EBITDA -283.92M
Net income avi to common (ttm)-284.23M
Diluted EPS (ttm)-3.0370
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)235.59M
Total cash per share (mrq)2.38
Total debt (mrq)170.46M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.52
Book value per share (mrq)-2.07

Cash flow statement

Operating cash flow (ttm)-315.02M
Levered free cash flow (ttm)-220.02M